General Population | Baseline D2304/2306, n = 7 | End D2306, n = 7 | Last Visit, n = 7 | |
---|---|---|---|---|
FACIT-F | 43.5 | 25.1 ± 11.3 | 42.6 ± 5.8* | 42.3 ± 6.9* |
SF-36 PCS | 50 | 37.7 ± 4.8 | 49.7 ± 4.9* | 48.6 ± 10.6* |
SF-36 MCS | 50 | 34.1 ± 11.4 | 44.1 ± 9 | 43.9 ± 8.7 |
HAQ | — | 0.64 ± 0.73 | 0.32 ± 0.56 | 0.52 ± 0.83 |
↵* p value < 0.05. FACIT-F: Functional Assessment of Chronic Illness Therapy-Fatigue; SF-36: Medical Outcomes Study Short Form-36 survey; PCS: physical component summary; MCS: mental component summary; HAQ: Health Assessment Questionnaire; D2304/2306: canakinumab/CAPS study.